BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28697830)

  • 1. [Value of serum miR-17-92 cluster in diagnosis of retinoblastoma].
    Chen YZ; Liu ZP; Zhou KY; Li B
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):776-780. PubMed ID: 28697830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MiR-17-92 Gene Cluster is a Blood-Based Marker for Cancer Detection in Non-Small-Cell Lung Cancer.
    Yang C; Jia X; Zhou J; Sun Q; Ma Z
    Am J Med Sci; 2020 Sep; 360(3):248-260. PubMed ID: 32466856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
    Wang H; Wei X; Wu B; Su J; Tan W; Yang K
    Cancer Manag Res; 2019; 11():3351-3360. PubMed ID: 31114371
    [No Abstract]   [Full Text] [Related]  

  • 5. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
    Sand M; Hessam S; Amur S; Skrygan M; Bromba M; Stockfleth E; Gambichler T; Bechara FG
    J Dermatol Sci; 2017 May; 86(2):142-148. PubMed ID: 28187958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
    Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
    PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBMCs to Stress-Associated miR-18a-5p and miR-22-3p Ratios as New Indicators of Metabolic Syndrome.
    Huang Y; Zhao L; Yan Y; Chen J; Liu P; Xv W; Qian G; Li C; Liang S; Zou H; Li Y
    Biomed Res Int; 2020; 2020():8159342. PubMed ID: 32382575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma.
    Li XH; Shi AJ; Li J; Yuan HF
    Int Ophthalmol; 2021 Jul; 41(7):2505-2512. PubMed ID: 33772700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
    Hirajima S; Komatsu S; Ichikawa D; Takeshita H; Konishi H; Shiozaki A; Morimura R; Tsujiura M; Nagata H; Kawaguchi T; Arita T; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2013 May; 108(9):1822-9. PubMed ID: 23579215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of serum miR-155-5p and miR-133a-3p expression for the diagnosis and prognosis evaluation of sepsis].
    Lan C; Shi X; Guo N; Pei H; Zhang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):694-8. PubMed ID: 27434558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
    He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
    World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
    Morimura R; Komatsu S; Ichikawa D; Takeshita H; Tsujiura M; Nagata H; Konishi H; Shiozaki A; Ikoma H; Okamoto K; Ochiai T; Taniguchi H; Otsuji E
    Br J Cancer; 2011 Nov; 105(11):1733-40. PubMed ID: 22045190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis.
    Cosar E; Mamillapalli R; Ersoy GS; Cho S; Seifer B; Taylor HS
    Fertil Steril; 2016 Aug; 106(2):402-9. PubMed ID: 27179784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.